Bloomberg News

U.S. Stocks Fall on Economic Data as Fed Maintains Plan

May 01, 2013

U.S. Stocks Decline Before Federal Reserve Policy Statement

Traders work on the floor of the New York Stock Exchange. The S&P 500 fell 0.2 percent to 1,594.65 at 9:31 a.m. in New York. Photographer: Scott Eells/Bloomberg

U.S. stocks fell, dragging the Standard & Poor’s 500 Index from a record high, on slower growth in American payrolls and manufacturing as the Federal Reserve said it will maintain its bond buying to support the economy.

Commodity companies dropped the most among 10 S&P 500 industries as oil and copper tumbled. Merck & Co. slid 2.8 percent after cutting its full-year forecast. Allergan (AGN:US) Inc. slumped 13 percent after delaying further study of an experimental drug for age-related macular degeneration. Comcast Corp. and Viacom (VIA:US) Inc. gained more than 1.3 percent after the media companies reported quarterly profits.

The S&P 500 fell 0.9 percent to 1,582.70 at 4 p.m. in New York. The Dow Jones Industrial Average slipped 138.85 points, or 0.9 percent, to 14,700.95. More than 6.6 billion shares changed hands on U.S. exchanges, or 4.4 percent above the three-month average.

“It’s more of the same,” Kevin Holt, who oversees the $9.7 billion Invesco Comstock Fund in Houston, said in a phone interview. “The existing policy guideline kind of continues. We didn’t expect anything different out of the Fed at this point of time. We had a good run. For the market to go higher, we need to see stronger economic growth, we need to see more sustainable employment growth.”

The Fed will maintain its bond buying at a pace of $85 billion a month, the Federal Open Market Committee said at the conclusion of a two-day meeting in Washington. It left unchanged its statement that it plans to hold its target interest rate near zero as long as unemployment remains above 6.5 percent and the outlook for inflation doesn’t exceed 2.5 percent.

Jobs Report

Stocks dropped earlier as a report showed companies added fewer workers than forecast in April. The 119,000 increase in payrolls, the smallest since September, followed a revised 131,000 gain in March that was less than initially estimated, according to data from ADP Research Institute. The median forecast of 37 economists surveyed by Bloomberg projected a 150,000 advance.

“The ADP report is somewhat disappointing because it’s just further evidence of slowdown,” Tom Wirth, who helps manage $1.6 billion as senior investment officer for Chemung Canal Trust Co., in Elmira, New York, said in a telephone interview.

The Labor Department publishes its jobs and unemployment report on May 3. Combined payrolls for companies and government agencies increased by 148,000 workers in April after rising 88,000 in March, according to a survey of economists by Bloomberg.

Record High

The S&P 500 (SPX) climbed to a record yesterday as consumer confidence jumped and investors bet central banks around the world will continue their efforts to stimulate the economy. The bull market in U.S. equities has entered its fifth year, surging 134 percent from a 12-year low in 2009 on better-than-estimated corporate earnings and three rounds of bond purchases by the Fed.

Among other economic reports today, the Institute for Supply Management’s factory index fell to 50.7 in April from the prior month’s 51.3. Chinese and Australian reports also signaled a slowdown in manufacturing. Construction spending in the U.S. decreased 1.7 percent to an $856.7 billion annual rate, the least since August, the Commerce Department reported.

Earnings Season

Investors also watched corporate earnings today. Of the 342 companies in the S&P 500 that have reported so far, 73 percent exceeded analysts’ predictions while 55 percent missed on sales, data compiled by Bloomberg show. Profit at S&P 500 companies rose 1.1 percent in the first three months of the year, according to analysts’ projections compiled by Bloomberg.

“During earnings season, you’re going to get some resets of expectations and the reality of what the underlying fundamentals look like,” Edward Painvin, chief investment officer of the Chase Investment Counsel Corp., which oversees $600 million, said by phone from Charlottesville, Virginia. “Expectations were a little bit ahead of themselves. This is a reset of expectations.”

The Chicago Board Options Exchange Volatility Index (VIX), or VIX, climbed 7.2 percent to 14.49 today as investors stepped up hedging against losses in the S&P 500. The gauge for options hit a six-year low in March and is down 20 percent this year.

Companies whose earnings are most tied to economic growth led the retreat. The Morgan Stanley Cyclical Index declined 1.4 percent and the Dow Jones Transportation Average tumbled 2.3 percent. The Russell 2000 Index of small companies sank 2.5 percent.

Commodity Slump

All 10 S&P 500 groups fell, with energy and raw-materials stocks sinking at least 1.6 percent.

Cliffs Natural Resources Inc., the largest U.S. iron-ore producer, dropped 4.7 percent to $20.33 as the S&P GSCI gauge of 24 commodities fell 2.1 percent. Marathon Petroleum Corp. erased 6.2 percent to $73.47.

QEP Resources Inc. lost 6.1 percent to $26.95 after earnings trailed analysts’ estimates.

Merck (MRK:US) fell 2.8 percent to $45.69. The company cut its full-year projections, citing estimates for lower sales, and said it plans to buy back $15 billion in shares. Merck has been eliminating thousands of jobs and trying to boost demand of existing products to overcome the revenue drop from its once-leading drug Singulair, an asthma medication that began facing competition from cheaper copies in August.

MasterCard Inc. fell 2.4 percent to $539.82. The second-biggest U.S. payments network reported first-quarter revenue that missed analysts’ estimates.

Allergan, Regeneron

Allergan, the maker of the Botox wrinkle treatment, plunged 13 percent to $98.67 for the biggest drop since 1999. Chief Executive Officer David Pyott said on a conference call that current data don’t support taking the DARPin medicine into the final stages of trials needed for regulatory approval.

Regeneron Pharmaceuticals Inc., which makes potential rival eye medicine Eylea, surged 10 percent to a record $237.29. Regeneron replaced MetroPCS Communications Inc. in the S&P 500 after the close of trading yesterday.

T-Mobile US Inc. (TMUS:US), the fourth-biggest U.S. wireless company, jumped 6 percent to $16.52 in its first day trading on the New York Stock Exchange after a merger (TMUS:US) with MetroPCS Communications, a smaller rival.

Comcast gained 1.4 percent to $41.86. The largest U.S. cable company and the owner of NBC Universal said first-quarter profit rose 17 percent as U.S. residential video subscriber revenue increased at the highest rate in four years.

Viacom Jumps

Viacom added 3 percent to $65.90. The owner of cable networks Nickelodeon and MTV as well as the Paramount film studio reported fiscal second-quarter profit that exceeded analysts’ estimates on improved advertising sales.

Humana (HUM:US) Inc. climbed 4.7 percent to $77.56 after the second-biggest private provider of Medicare coverage boosted its full-year earnings forecast to a range of $8.40 to $8.60 a share. That topped the average analyst estimate of $7.95 in a Bloomberg survey.

DreamWorks Animation SKG Inc. rose 7.3 percent to $20.69. The studio run by Jeffrey Katzenberg posted a surprise profit, helped by its box-office hit “The Croods” and television revenue from “Madagascar 3: Europe’s Most Wanted.”

To contact the reporters on this story: Lu Wang in New York at lwang8@bloomberg.net; Whitney Kisling in New York at wkisling@bloomberg.net

To contact the editors responsible for this story: Lynn Thomasson at lthomasson@bloomberg.net


We Almost Lost the Nasdaq
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

Companies Mentioned

  • AGN
    (Allergan Inc/United States)
    • $171.29 USD
    • -1.14
    • -0.66%
  • VIA
    (Viacom Inc)
    • $86.0 USD
    • 0.01
    • 0.01%
Market data is delayed at least 15 minutes.
 
blog comments powered by Disqus